Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Radenkovic

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Translational Medicine|February 21, 2026
PGM1 deficiency is linked to sarcomeric and mitochondrial dysfunction in patient-derived iPSC-cardiomyocytesSilvia Radenkovic, Graeme Preston, Rohit Budhraja, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 19, 2022
TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disabilitySilvia Radenkovic, Diego Martinelli, Yuebo Zhang, et al.
American Journal of Human Genetics|May 12, 2021
Impaired glucose-1,6-biphosphate production due to bi-allelic PGM2L1 mutations is associated with a neurodevelopmental disorderEva Morava, Ulrich A Schatz, Pernille M Torring, et al.
Molecular Genetics and Metabolism|November 1, 2020
Expanding the clinical and metabolic phenotype of DPM2 deficient congenital disorders of glycosylationSilvia Radenkovic, Taylor Fitzpatrick-Schmidt, Seul Kee Byeon, et al.
Cells|January 28, 2026
Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDGRameen Shah, Rohit Budhhraja, Silvia Radenkovic, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
ALG13 loss-of-function alters glycosylation, impairs neuronal maturation, and drives network hypoactivity in a cortical organoid model of CDGRameen Shah, Rohit Budhraja, Silvia Radenkovic, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Novel mouse model reveals neurodevelopmental origin of PMM2-CDG brain pathologyAndrew C Edmondson, Rohit Budhraja, Zijie Xia, et al.
Journal of Inherited Metabolic Disease|April 9, 2020
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylationAnna Čechová, Ruqaiah Altassan, Delphine Borgel, et al.
Cell Reports. Medicine|May 31, 2023
Tracer metabolomics reveals the role of aldose reductase in glycosylationSilvia Radenkovic, Anna N Ligezka, Sneha S Mokashi, et al.
JCI Insight|April 8, 2024
A complement C4-derived glycopeptide is a biomarker for PMM2-CDGKishore Garapati, Rohit Budhraja, Mayank Saraswat, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Translational Medicine|February 21, 2026
PGM1 deficiency is linked to sarcomeric and mitochondrial dysfunction in patient-derived iPSC-cardiomyocytesSilvia Radenkovic, Graeme Preston, Rohit Budhraja, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 19, 2022
TRAPPC9-CDG: A novel congenital disorder of glycosylation with dysmorphic features and intellectual disabilitySilvia Radenkovic, Diego Martinelli, Yuebo Zhang, et al.
American Journal of Human Genetics|May 12, 2021
Impaired glucose-1,6-biphosphate production due to bi-allelic PGM2L1 mutations is associated with a neurodevelopmental disorderEva Morava, Ulrich A Schatz, Pernille M Torring, et al.
Molecular Genetics and Metabolism|November 1, 2020
Expanding the clinical and metabolic phenotype of DPM2 deficient congenital disorders of glycosylationSilvia Radenkovic, Taylor Fitzpatrick-Schmidt, Seul Kee Byeon, et al.
Cells|January 28, 2026
Network Hypoactivity in ALG13-CDG: Disrupted Developmental Pathways and E/I Imbalance as Early Drivers of Neurological Features in CDGRameen Shah, Rohit Budhhraja, Silvia Radenkovic, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
ALG13 loss-of-function alters glycosylation, impairs neuronal maturation, and drives network hypoactivity in a cortical organoid model of CDGRameen Shah, Rohit Budhraja, Silvia Radenkovic, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Novel mouse model reveals neurodevelopmental origin of PMM2-CDG brain pathologyAndrew C Edmondson, Rohit Budhraja, Zijie Xia, et al.
Journal of Inherited Metabolic Disease|April 9, 2020
Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylationAnna Čechová, Ruqaiah Altassan, Delphine Borgel, et al.
Cell Reports. Medicine|May 31, 2023
Tracer metabolomics reveals the role of aldose reductase in glycosylationSilvia Radenkovic, Anna N Ligezka, Sneha S Mokashi, et al.
JCI Insight|April 8, 2024
A complement C4-derived glycopeptide is a biomarker for PMM2-CDGKishore Garapati, Rohit Budhraja, Mayank Saraswat, et al.
Pageof 4